Clinical Trial Update: Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine [Phase 4]

View source ↗

Summary

Completed Phase 4 trial assessing safety and immunogenicity of one or two doses of inactivated poliovirus vaccine in Latin American infants primed with bivalent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Inactivated Poliovirus Vaccine (Inactivated Poliovirus Vaccine)

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED